Tuberculosis in children exposed at home to multidrug-resistant tuberculosis

Mercedes C Becerra1, Molly F Franke, Sasha C Appleton

  • 1Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA. mbecerra@post.harvard.edu

Insights

Children exposed to multidrug-resistant tuberculosis (MDR-TB) face a high risk of developing TB disease, especially in the first year after diagnosis of an infectious household member. This underscores the urgent need for pediatric contact investigations and prompt treatment.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • The global burden of tuberculosis (TB) in children exposed to multidrug-resistant tuberculosis (MDR-TB) within households remains largely unquantified.
  • Millions of children worldwide are chronically exposed to infectious MDR-TB patients due to limited treatment access.

Purpose of the Study:

  • To quantify the burden of TB disease among child household contacts of MDR-TB patients.
  • To estimate the prevalence and incidence of TB disease in children exposed to MDR-TB.

Main Methods:

  • A retrospective cohort study was conducted in Lima, Peru, from 1996 to 2003.
  • Included child and adult household contacts of patients treated for MDR-TB.
  • Primary outcome was TB disease, with prevalence estimated at index case treatment start and incidence tracked over 4 years.

Main Results:

  • Among 1299 child contacts, TB prevalence was 1771 per 100,000 children.
  • TB incidence was highest in the first year (2079 per 100,000 child-years), remaining elevated over 4 years.
  • Child contacts exhibited TB disease rates approximately 30 times higher than the general pediatric population, with 20% of TB cases occurring in children.

Conclusions:

  • Children exposed to MDR-TB patients face a significant risk of TB disease at the time of diagnosis and in the subsequent year.
  • Highlights the critical need for contact investigations and timely referral/treatment systems for pediatric household contacts of MDR-TB patients.
  • Recommendations apply regardless of the child's age, emphasizing universal screening and care.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...